Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$31.84
0.120.38%
At Close: -
$31.84
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Supernus Pharmaceuticals (SUPN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Quotes, Forecast and News Summary
Supernus Pharmaceuticals Stock (NASDAQ: SUPN) stock price, news, charts, stock research, profile.
| Open | $31.64 |
| Close | $31.84 |
| Volume / Avg. | 313.14K / 529.06K |
| Day Range | $31.59 - $32.59 |
| 52 Wk Range | 21.99 - 35.44 |
| Market Cap | $1.75B |
| P/E Ratio | 352.44 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | 18.5% |
| Days to Cover | 24.73 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Supernus Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in develo...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Supernus Pharmaceuticals (SUPN) stock?
You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.
Who are Supernus Pharmaceuticals (SUPN) competitors?
Other companies in Supernus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Phathom Pharmaceuticals (NASDAQ:PHAT).
What is the forecast, or price target, for Supernus Pharmaceuticals (SUPN) stock?
Supernus Pharmaceuticals has a consensus price target of $36.00.
What is the current price for Supernus Pharmaceuticals (SUPN)?
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $31.84 last updated September 18, 2024 at 4:00 PM EDT.
Does Supernus Pharmaceuticals (SUPN) pay a dividend?
There are no upcoming dividends for Supernus Pharmaceuticals.
When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?
Supernus Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Supernus Pharmaceuticals (SUPN) going to split?
There is no upcoming split for Supernus Pharmaceuticals.
What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.